Detalles de la búsqueda
1.
Low Prevalence of Interferon α Autoantibodies in People Experiencing Symptoms of Post-Coronavirus Disease 2019 (COVID-19) Conditions, or Long COVID.
J Infect Dis
; 227(2): 246-250, 2023 01 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36089700
2.
SARS-CoV-2 Serology Across Scales: A Framework for Unbiased Estimation of Cumulative Incidence Incorporating Antibody Kinetics and Epidemic Recency.
Am J Epidemiol
; 192(9): 1562-1575, 2023 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37119030
3.
Characterizing the COVID-19 Illness Experience to Inform the Study of Post-acute Sequelae and Recovery.
Int J Behav Med
; 29(5): 610-623, 2022 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-34918211
4.
Markers of Immune Activation and Inflammation in Individuals With Postacute Sequelae of Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
J Infect Dis
; 224(11): 1839-1848, 2021 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34677601
5.
Effects of Dietary Fructose Restriction on Liver Fat, De Novo Lipogenesis, and Insulin Kinetics in Children With Obesity.
Gastroenterology
; 153(3): 743-752, 2017 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-28579536
6.
Chronic viral coinfections differentially affect the likelihood of developing long COVID.
J Clin Invest
; 133(3)2023 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36454631
7.
Multimodal Molecular Imaging Reveals Tissue-Based T Cell Activation and Viral RNA Persistence for Up to 2 Years Following COVID-19.
medRxiv
; 2023 Jul 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-37577714
8.
Role of antibodies, inflammatory markers, and echocardiographic findings in postacute cardiopulmonary symptoms after SARS-CoV-2 infection.
JCI Insight
; 7(10)2022 05 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-35389890
9.
Impact of Pre-Existing Chronic Viral Infection and Reactivation on the Development of Long COVID.
medRxiv
; 2022 Jul 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-35898346
10.
Postacute sequelae and adaptive immune responses in people with HIV recovering from SARS-COV-2 infection.
AIDS
; 36(12): F7-F16, 2022 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35866847
11.
Plasma Markers of Neurologic Injury and Inflammation in People With Self-Reported Neurologic Postacute Sequelae of SARS-CoV-2 Infection.
Neurol Neuroimmunol Neuroinflamm
; 9(5)2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35701186
12.
Persistence, Magnitude, and Patterns of Postacute Symptoms and Quality of Life Following Onset of SARS-CoV-2 Infection: Cohort Description and Approaches for Measurement.
Open Forum Infect Dis
; 9(2): ofab640, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-35106317
13.
SARS-CoV-2 serology across scales: a framework for unbiased seroprevalence estimation incorporating antibody kinetics and epidemic recency.
medRxiv
; 2021 Sep 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-34545373
14.
Characterizing the COVID-19 illness experience to inform the study of post-acute sequelae and recovery: a qualitative study.
medRxiv
; 2021 Mar 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-33758881
15.
Long-term SARS-CoV-2-specific immune and inflammatory responses in individuals recovering from COVID-19 with and without post-acute symptoms.
Cell Rep
; 36(6): 109518, 2021 08 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34358460
16.
Long-Term SARS-CoV-2-Specific Immune and Inflammatory Responses Across a Clinically Diverse Cohort of Individuals Recovering from COVID-19.
medRxiv
; 2021 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33688685
17.
Rapid implementation of a cohort for the study of post-acute sequelae of SARS-CoV-2 infection/COVID-19.
medRxiv
; 2021 Mar 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-33758895
18.
SARS-CoV-2 antibody magnitude and detectability are driven by disease severity, timing, and assay.
Sci Adv
; 7(31)2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-34330709
19.
SARS-CoV-2 antibody magnitude and detectability are driven by disease severity, timing, and assay.
medRxiv
; 2021 Mar 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33688675
20.
Short-term isocaloric fructose restriction lowers apoC-III levels and yields less atherogenic lipoprotein profiles in children with obesity and metabolic syndrome.
Atherosclerosis
; 253: 171-177, 2016 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-27451002